Our subsequent query of NSCLC data from The Cancer Genome Atlas (TCGA) revealed a high frequency of SLITRK3 amplification in LUSC tumors (30% versus < 5% in LUAD, Fig. 1b). The gene discussed is SLITRK3; the disease is non-small cell lung carcinoma.